Strategic Planning
-
Response Time2 Hours
-
Delivery Time4 Weeks
-
Location
Service Description
Lumanity provides comprehensive strategic planning to guide drug development programs from early concept through late-stage clinical execution. Their cross-functional teams integrate clinical, CMC, regulatory, and preclinical insights to identify development risks, accelerate timelines, and maximize the probability of regulatory success. By assessing the entire development landscape, Lumanity ensures your program follows the most efficient and scientifically defensible path to approval.
What This Service Includes
Full cross-functional assessments (clinical, CMC, preclinical)
Identification of critical development inflection points
Integrated development plan creation
Early-stage feasibility and target product profile alignment
Strategic recommendations to streamline time, cost, and risk.
Frequently Asked Questions
What is typically included in a cross-functional assessment?
Clinical strategy, CMC readiness, nonclinical data review, program gaps, regulatory considerations, and timeline risks.
At what stage should companies engage for strategic planning?
Ideal from preclinical through Phase 1, but valuable at any development stage.
Can Lumanity help define a Target Product Profile (TPP)?
Yes — Lumanity develops TPPs aligned with regulatory expectations and commercial goals.
Does this service support global development planning?
Absolutely. Lumanity integrates FDA, EMA, and global pathways into the strategy.
About The Seller
Location:
New Jersey






